Duchenne Muscular Dystrophy  >>  Duvyzat (givinostat) 
Welcome,         Profile    Billing    Logout  

2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
ULYSSES, NCT05933057: Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

Recruiting
3
138
Europe, Canada
Givinostat, ITF2357, Placebo
Italfarmaco, Fortrea
Duchenne Muscular Dystrophy
02/28
02/28
NCT03373968 / 2017-000397-10: Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

Enrolling by invitation
2/3
206
Europe, Canada, US, RoW
Givinostat
Italfarmaco, Cromsource
Duchenne Muscular Dystrophy
12/25
12/25

Download Options